Estimations des analystes de Wall Street pour Health Catalyst, Inc. (HCAT): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-09 | $-0.02 | ||
| 2026-08-06 | $0.04 | $0.03 | +33.9% |
| 2026-05-11 | $0.02 | $0.01 | +100.0% |
| 2026-03-12 | $0.08 | $0.09 | -11.1% |
| 2025-11-10 | $0.06 | $0.05 | +20.0% |
| 2025-08-07 | $0.04 | $0.03 | +33.3% |
| 2025-05-07 | $0.01 | $0.01 | +0.0% |
| 2025-02-26 | $0.04 | $0.11 | -63.6% |
Ratios de valorisation
| Prix / Valeur comptable | 1.33 |
| EV / EBITDA | -1.25 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenus | $73.1M | $112.6M | $154.9M | $188.8M | $241.9M | $276.2M | $295.9M | $306.6M | $311.1M |
| Coût des Ventes | $43.6M | $59.9M | $75.3M | $98.1M | $124.4M | $143.0M | $164.1M | $165.8M | $207.0M |
| Marge Brute | $29.4M | $52.7M | $79.6M | $90.8M | $117.6M | $133.2M | $131.8M | $140.8M | $104.1M |
| R&D | $28.5M | $38.6M | $46.3M | $53.5M | $62.7M | $75.7M | $72.6M | $58.0M | $49.8M |
| Frais Généraux | $40.6M | $66.8M | $79.0M | $114.7M | $161.0M | $149.2M | $143.9M | $111.2M | $102.0M |
| Charges Opérationnelles | $75.0M | $112.8M | $134.5M | $186.9M | $261.2M | $273.2M | $258.7M | $210.6M | $140.2M |
| Résultat Opérationnel | -$45.5M | -$60.1M | -$54.9M | -$96.1M | -$143.7M | -$140.0M | -$126.9M | -$69.8M | -$36.1M |
| EBITDA | -$39.7M | -$52.1M | -$47.3M | -$85.9M | -$101.7M | -$82.9M | -$68.3M | -$10.7M | -$110.4M |
| Charges d'Intérêt | $2.0M | $2.6M | $6.3M | $13.7M | $17.3M | $7.2M | $7.3M | $17.1M | $16.4M |
| Résultat Avant Impôts | -$47.0M | -$62.1M | -$60.0M | -$116.2M | -$160.1M | -$141.7M | -$117.8M | -$69.2M | -$177.3M |
| Impôts | $26000 | -$135000 | $142000 | -$1.2M | -$6.9M | -$4.3M | $356000 | $333000 | $716000 |
| Résultat Net | -$47.0M | -$62.0M | -$60.1M | -$115.0M | -$153.2M | -$137.4M | -$118.1M | -$69.5M | -$178.0M |
| BPA | $-1.69 | $-2.23 | $-3.21 | $-2.91 | $-3.23 | $-2.56 | $-2.09 | $-1.15 | $-2.55 |
| BPA Dilué | $-1.69 | $-2.23 | $-3.21 | $-2.91 | $-3.23 | $-2.54 | $-2.09 | $-1.15 | $-2.55 |
| Actions en Circulation (Diluées) | $27.8M | $27.8M | $18.7M | $39.5M | $47.5M | $54.1M | $56.4M | $60.2M | $69.9M |
Prix
| Prix | $1.79 |
| Capitalisation | $132M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: CRBU · ENTA · HSDT · NNOX · OBIO · OM · PRLD
Explorer le secteur: Healthcare · Medical - Healthcare Information Services
Plus de sections de HCAT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions